TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

54.30 +0.01 (+0.02%)

Delayed Quote Updated: 11:34 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TG Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Why NASDAQ:TGTX is Poised for High Growth. ↗

September 09, 2024

Exploring TG THERAPEUTICS INC (NASDAQ:TGTX)'s growth characteristics.

Via Chartmill

In the world of growth stocks, NASDAQ:TGTX shines as a value proposition. ↗

August 28, 2024

NASDAQ:TGTX, a growth stock which is not overvalued.

Via Chartmill

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 19, 2024

Via Benzinga

IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter ↗

August 19, 2024

The company reported a surprise profit in the second quarter, vs. expectations for losses.

Via Investor's Business Daily

Decoding TG Therapeutics's Options Activity: What's the Big Picture? ↗

August 19, 2024

Via Benzinga

Why the growth investor may take a look at NASDAQ:TGTX. ↗

August 19, 2024

Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for growth investing?

Via Chartmill

A Closer Look at TG Therapeutics's Options Market Dynamics ↗

August 16, 2024

Via Benzinga

NASDAQ:TGTX: a strong growth stock preparing for the next leg up?. ↗

August 13, 2024

TG THERAPEUTICS INC (NASDAQ:TGTX) qualifies as a high growth stock and is consolidating.

Via Chartmill

ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday ↗

August 19, 2024

Via Benzinga

Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review ↗

August 09, 2024

After Monday's panicked global sell-off, markets have calmed down.

Via Investor's Business Daily

NASDAQ:TGTX is showing decent growth, but is still valued reasonably. ↗

August 07, 2024

NASDAQ:TGTX stands out as a growth opportunity that won't break the bank.

Via Chartmill

S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates ↗

August 06, 2024

Via Benzinga

Topics Earnings Stocks

$1000 Invested In TG Therapeutics 5 Years Ago Would Be Worth This Much Today ↗

July 12, 2024

Via Benzinga

(TGTX) - Analyzing TG Therapeutics's Short Interest ↗

June 04, 2024

Via Benzinga

Peering Into TG Therapeutics's Recent Short Interest ↗

May 14, 2024

Via Benzinga

Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings ↗

August 06, 2024

Via Benzinga

TGTX Stock Earnings: TG Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

TGTX stock results show that TG Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday ↗

August 06, 2024

Via Benzinga

TG Therapeutics Stock Jumps As Surprise Profit Smashes Views By 157% ↗

August 06, 2024

The company unexpectedly reported profit in the second quarter, handily beating views for a per-share loss.

Via Investor's Business Daily

In the world of growth stocks, NASDAQ:TGTX shines as a value proposition. ↗

July 11, 2024

Looking for growth without the hefty price tag? Consider TG THERAPEUTICS INC (NASDAQ:TGTX).

Via Chartmill

"Rule Breaker Investing" Market Cap Game Show: Bill Mann vs. Bill Barker ↗

June 27, 2024

Our first-ever twin bill.

Via The Motley Fool

Nasdaq 100 Overbought? Here’s What History Says About The Current Rally ↗

June 26, 2024

Find out the historical patterns traders can look for to anticipate the next move in the Nasdaq 100.

Via Talk Markets

The Most Shorted Stocks in June: Hold, Short, or Squeeze?

June 18, 2024

Given the proper catalyst, the short interest in these stocks may lead to a short squeeze. All the market needs is a push and it may come at any time.

Via MarketBeat

Why TG Therapeutics Stock Was Rocketing Higher This Week ↗

May 03, 2024

The company raised guidance for sales of its drug for relapsing multiple sclerosis.

Via The Motley Fool

Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises

June 11, 2024

EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END

Via FinancialNewsMedia

TGTX Stock Earnings: TG Therapeutics Misses EPS, Beats Revenue for Q1 2024 ↗

May 01, 2024

TGTX stock results show that TG Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

TG Therapeutics stock just rallied 30%: what happened? ↗

May 01, 2024

TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for its fiscal first quarter.

Via Talk Markets

Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises

June 11, 2024

From FN Media Group LLC

Via GlobeNewswire

Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday ↗

May 01, 2024

Via Benzinga

Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 01, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.